OTC reforms built to last?

Reform of derivatives markets is gathering pace in the US ahead of a crucial debate in the House of Representatives. But questions remain over exemptions for corporate hedgers and foreign exchange swaps and forwards, meaning the final architecture of the new framework is far from clear. By Peter Madigan

risk-dec-cover-story-image

"Laws are like sausages; it’s better not to see them being made,” so Otto von Bismarck, the first German chancellor, allegedly observed. The idiom is very relevant today after three months of exhaustive hearings, discussion drafts, amendments and votes as lawmakers in Washington, DC look to overhaul the supervision of financial markets in the US.

Efforts to comprehensively regulate the over-the-counter derivatives market have cranked up a gear since mid-October, when two House of Representatives

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here